Browsing by Author Zannino, Diana

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)Citation
2012Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin CSimes, Robert John; Tebbutt, Niall; Wilson, Catherine; Zannino, Diana; Ackland, Stephen P.; Broad, A; Cassidy, J; Ganju, V.; Price, Timothy; Robinson, B; Van Hazel, Guy Arthur; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreBevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C, Annals of Oncology, vol.23, 6, 2012,pp 1531-1536
2011Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast CancerCoates, Alan; Gebski, Val; Grimison, Peter; Stockler, Martin; Wilcken, Nicholas; Zannino, Diana; Ackland, Stephen; Byrne, Michael J.; Fitzharris, B; Fong, A.; Forbes, John; Francis, Prudence; Gainford, Corona; Harvey, V; Nowak, Anna; Paksec, Lisa; Simes, John; Sourjina, Tatiana; Van Hazel, Guy; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials CentreCapecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer, Journal of Clinical Oncology, vol.29, 34, 2011,pp 4498-4504
2010Capecitabine, Bevacizumab and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized, Phase III MAX Study.Gebski, Val; Simes, Robert John; Stockler, Martin; Zannino, Diana; Ackland, Stephen P.; Broad, Adam; Chua, Yu Jo; Cummins, Michelle; Cunningham, David; Forgeson, Garry; Ganju, Vinod; Price, Timothy; Robinson, Bridget; Saunders, M; Tebbutt, Niall C; van Hazel, Guy; Wilson, Kate; Zalcberg, J; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCapecitabine, Bevacizumab and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized, Phase III MAX Study., Journal of Clinical Oncology (Online), vol.28, 19,pp 3191-3198
2011Clinical and Pathological Features of Metastases of Primary Cutaneous Desmoplastic MelanomaMcCarthy, Stanley; Murali, Rajmohan; Scolyer, Richard; Thompson, John; Zannino, Diana; Synnott, Maria; Central Clinical School: Inst. of Anatomical Pathology RPAH; Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Surgery; School of Public Health: NH&MRC Clinical Trials CentreClinical and Pathological Features of Metastases of Primary Cutaneous Desmoplastic Melanoma, Histopathology, vol.58, 6, 2011,pp 886-895
2018Clinical Outcomes in Adolescents and Adults After the Fontan ProcedureCelermajer, David; Cordina, Rachael; Dennis, Mark; Bullock, Andrew; Disney, Patrick; du Plessis, Karin; d'Udekem, Yves; Grigg, Leeanne Elizabeth; Hornung, Tim; Radford, Dorothy; Zannino, Diana; Central Clinical School: Medicine; Central Clinical School: Medicine; MedicineClinical Outcomes in Adolescents and Adults After the Fontan Procedure, Journal of the American College of Cardiology, vol.71, 9, 2018,pp 1009-1017
2017Common atrioventricular valve failure during single ventricle palliationWinlaw, David; Alphonso, Nelson; Bullock, A; Buratto, Edward; Cordina, Rachel; d'Udekem, Yves; Gentles, Thomas; Grigg, Leeanne Elizabeth; King, Gregory; Radford, Dorothy; Zannino, Diana; Childrens Hospital Westmead: Paediatrics & Child HealthCommon atrioventricular valve failure during single ventricle palliation, European Journal Of Cardio-Thoracic Surgery, vol.51, 6, 2017,pp 1037-1043
2014The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: Results from the Australasian phase III MAX studyCarter, Hannah; Howard, Kirsten; Schofield, Deborah; Simes, Robert John; Zannino, Diana; Price, Timothy; Tebbutt, Niall C; Zalcberg, John; Anaesthesia; School of Public Health: Public Health; Pharmacy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: Results from the Australasian phase III MAX study, European Journal of Cancer, vol.50, 3, 2014,pp 535-543
2017Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraIland, Harry; Appelbaum, Frederick; Collins, Marnie; Devlin, Sean; Douer, Dan; et al, Various; Goldman, Debra; Lee, Ju-Whei; Litzow, Mark; Mantha, Simon; Stein, Eytan; Zannino, Diana; Central Clinical School: MedicineDeterminants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era, Blood, vol.129, 13, 2017,pp 1763-1767
2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trialGebski, Val; Parry, M M; Pavlakis, Nick; Zannino, Diana; Dobrovic, Alexander N; Ganju, V.; Mellor, D; Strickland, A. H.; Tebbutt, Niall C; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreDocetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial, British Journal of Cancer, vol.108, 4, 2013,pp 771-774
2011Estimated Glomerular Filtration Rate and Albuminuria are Independent Predictors of Cardiovascular Events and Death in Type 2 Diabetes Mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDrury, Paul; Keech, Anthony (Tony); Pardy, Christopher; Ting, Ru Dee; Zannino, Diana; Ansquer, Jean-Claude; Colman, P. G.; Davis, T. M. E.; Dixon, P; Ehnholm, Christian; Fassett, Robert; Flack, Jeff; Whiting, M. J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEstimated Glomerular Filtration Rate and Albuminuria are Independent Predictors of Cardiovascular Events and Death in Type 2 Diabetes Mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study, Diabetologia: clinical and experimental diabetes and metabolism, vol.54, 1, 2011,pp 32-43
2014Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyKeech, Anthony (Tony); Li, Li Ping; Mann, Kristy; Zannino, Diana; Best, James; dEmden, Michael; Jenkins, Alicia; Park, Kris; Saltevo, Juha; Stuckey, B G A; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFavourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, Diabetologia, vol.57, 11, 2014,pp 2296-2303
2016Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerPavlakis, Nick; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Wong, Nicole; Burns, Ivon; Jefford, Michael; Moylan, Eugene; Price, Timothy; Ransom, David; Schofield, Penelope; Tebbutt, Niall; Underhill, Craig; Ward, R; Wyld, David; Zannino, Diana; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreHope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer, Supportive Care in Cancer, vol.24, 1, 2016,pp 401-408
2015Identification of the sentinel lymph node in the SNAC-1 trialGebski, Val; Simes, Robert John; Stockler, Martin; Uren, Roger; Zannino, Diana; Bochner, Melissa A.; Campbell, Ian; Elmadahm, Amira; Gill, Peter; Ung, Owen; Wetzig, Neil; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; NH&MRC Clinical Trials CentreIdentification of the sentinel lymph node in the SNAC-1 trial, ANZ Journal of Surgery, vol.85, 1-2, 2015,pp 58-63
2017Improved long-term outcomes in double-inlet left ventricle and tricuspid atresia with transposed great arteries: systemic outflow tract obstruction present at birth defines long-term outcomeAyer, Julian; Sholler, Gary; Winlaw, David; Admiraal, Manouk; Cole, Andrew; d'Udekem, Yves; Franken, Lotte C.; Iyengar, Ajay; Verrall, C; Zannino, Diana; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Medicine; Childrens Hospital Westmead: Paediatrics & Child HealthImproved long-term outcomes in double-inlet left ventricle and tricuspid atresia with transposed great arteries: systemic outflow tract obstruction present at birth defines long-term outcome, European Journal Of Cardio-Thoracic Surgery, vol.51, 6, 2017,pp 1051-1057
2010Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.Burgess, David; Keech, Anthony (Tony); Li, Li Ping; Sy, Raymond; Williamson, E; Zannino, Diana; Zhang, Jun; Davis, Timothy; Hunt, David; Kesaniemi, Y. Antero; Laakso, Markku; Lehto, Seppo; Mann, S; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: Psychological Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; AnaesthesiaIncidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study., European Heart Journal (English Edition), vol.31, 1,pp 92-99
2009Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with Type 2 diabetes treated with fenofibrateBarter, Philip; Keech, Anthony (Tony); Simes, Robert John; Sullivan, David; Zannino, Diana; Ehnholm, Christian; Taskinen, M.; Whiting, Malcolm; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRelationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with Type 2 diabetes treated with fenofibrate, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, 6, 2009,pp 950-955
2011Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumabCummins, Michelle; Marx, Gavin; Shannon, Jenny; Simes, Robert John; Wilson, Kate; Zannino, Diana; Abdi, Ehtesham A; Blum, R; Chantrill, L; Goldstein, D; Karapetis, Christos; Lowenthal, Raymond M.; Murphy, F; Nayagam, S; Price, Timothy; Strickland, A. H.; Tebbutt, Niall C; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; Nepean Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRisk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab, Annals of Oncology, vol.22, 8, 2011,pp 1834-1838
2015Sentinel Lymph Node Based Management or Routine Axillary Clearance? Three-year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 TrialGebski, Val; Simes, Robert John; Stockler, Martin; Zannino, Diana; Campbell, Ian; Gill, Peter; Ung, Owen; Wetzig, Neil; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSentinel Lymph Node Based Management or Routine Axillary Clearance? Three-year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial, Annals of Surgical Oncology, vol.22, 1, 2015,pp 17-23
2017Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedureCelermajer, David; Cordina, Rachael; Winlaw, David; Bullock, A; et al, Various; Gentles, Thomas; Grigg, Leanne; Hornung, Tim; Justo, Robert N; Poh, Chin Leng; Verrall, C; Weintraub, Robert G.; Zannino, Diana; Central Clinical School: Medicine; Central Clinical School: Medicine; Childrens Hospital Westmead: Paediatrics & Child HealthThree decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedure, International Journal of Cardiology, vol.231, N/A, 2017,pp 99-104